Forward this page to a friend

New Ambitious Research Programme Receives DKK 100 million for Research into Leukaemia and New Treatment

Professor Kristian Helin heads a new research programme, which has just received DKK 100 million from the Novo Nordisk Foundation. The programme, which falls under DanStem, is clinically focussed and aims to develop and test new forms of treatment for leukaemia.